Daily SignalsNeutral
2489 companies scored · 2026-10-14 run in progress: 1692 of ~5379 signals so far · Alpha · vs marketSwitch to Total · 30D 90D
Distribution of the day's forecasts
30D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
48 companies
Sorted by 30D forecast ↓
| Ticker | Rating | 30D | Δ |
|---|---|---|---|
| ARQTArcutis Biotherapeutics, Inc. | +0.19% | · | |
| COGTCogent Biosciences, Inc. | +0.18% | · | |
| COLLCOLLEGIUM PHARMACEUTICAL, INC | +0.18% | · | |
| MGTXMeiraGTx Holdings plc | +0.18% | · | |
| AMRXAmneal Pharmaceuticals, Inc. | +0.17% | · | |
| ABUSArbutus Biopharma Corp | +0.16% | · | |
| AXSMAxsome Therapeutics, Inc. | +0.15% | · | |
| BMRNBIOMARIN PHARMACEUTICAL INC | +0.15% | · | |
| LFCRLIFECORE BIOMEDICAL, INC. \DE\ | +0.15% | ▼ 1 | |
| RPRXRoyalty Pharma plc | +0.15% | · | |
| UTHRUNITED THERAPEUTICS Corp | +0.15% | · | |
| CYTKCYTOKINETICS INC | +0.06% | · | |
| PFEPFIZER INC | +0.01% | · | |
| VIRVir Biotechnology, Inc. | -0.01% | · | |
| ENGNenGene Therapeutics Inc. | -0.04% | · | |
| INDVIndivior Pharmaceuticals, Inc. | -0.04% | · | |
| ANABANAPTYSBIO, INC | -0.05% | · | |
| NRIXNurix Therapeutics, Inc. | -0.05% | · | |
| ARGXARGENX SE | -0.07% | · | |
| LENZLENZ Therapeutics, Inc. | -0.08% | · | |
| RADXRadiopharm Theranostics Ltd | -0.08% | · | |
| VTRSViatris Inc | -0.08% | · | |
| KRYSKrystal Biotech, Inc. | -0.09% | · | |
| MOLNMOLECULAR PARTNERS AG | -0.09% | · | |
| PLYXPolaryx Therapeutics, Inc. | -0.09% | · | |
| AGIOAGIOS PHARMACEUTICALS, INC. | -0.10% | · | |
| AUPHAurinia Pharmaceuticals Inc. | -0.10% | · | |
| BNTXBioNTech SE | -0.10% | ▲ 1 | |
| IDXXIDEXX LABORATORIES INC /DE | -0.10% | · | |
| INSMINSMED Inc | -0.10% | · | |
| IVAInventiva S.A. | -0.10% | · | |
| JNJJOHNSON & JOHNSON | -0.10% | ▲ 1 | |
| LKFTLakefront Biotherapeutics NV | -0.10% | · | |
| NBPNovaBridge Biosciences | -0.10% | · | |
| NRXPNRX Pharmaceuticals, Inc. | -0.10% | ▲ 1 | |
| NWBONORTHWEST BIOTHERAPEUTICS INC | -0.10% | · | |
| OMEROMEROS CORP | -0.10% | · | |
| ORMPORAMED PHARMACEUTICALS INC. | -0.10% | · | |
| QDELQuidelOrtho Corp | -0.10% | · | |
| VCELVericel Corp | -0.10% | · | |
| AMPHAmphastar Pharmaceuticals, Inc. | -0.11% | ▲ 1 | |
| BLRXBioLineRx Ltd. | -0.11% | ▲ 1 | |
| CGCCanopy Growth Corp | -0.11% | ▲ 1 | |
| CGENCOMPUGEN LTD | -0.11% | ▲ 1 | |
| ELANElanco Animal Health Inc | -0.11% | ▲ 1 | |
| LABSTANDARD BIOTOOLS INC. | -0.11% | · | |
| PAHCPHIBRO ANIMAL HEALTH CORP | -0.11% | ▲ 1 | |
| SMMTSummit Therapeutics Inc. | -0.11% | ▲ 1 |
By sector
Median 30D forecast per sector. Click to filter.
Rating changes
Unlock the full ranking
Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.
See plans Create a free accountRatings are relative: the forecasts of the latest complete daily run (2026-10-13) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.